Laxmi Dental Limited (LAXMIDENTL) fundamentals
Laxmi Dental Limited is a listed company in Healthcare Equipment & Supplies, part of the Healthcare sector, listed on the NSE as LAXMIDENTL (ISIN INE0WO601020). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Laxmi Dental Limited does
Laxmi Dental Limited is an end-to-end integrated dental products company. Its segments include Laboratory Business, Aligners Business, and Other Business. The Laboratory Business consists of dental prosthesis, such as metal free crowns and bridges, porcelain fused to metal (PFM) crowns and bridge dentures. The Aligners Business consists of dental aligners, retainers, raw materials for aligners, sport guards, night guards, sleep apnea devices. The Other Business consists of dental distribution products used in dental laboratories, dental clinical services and dental educational courses. It manufactures and supplies thermoforming sheets, thermoforming machines, dental consumables, biocompatible resins for 3D printing under its brand Taglus tailored for manufacturing of clear aligners. It offers a range of pediatric products, including pre-formed branded pediatric crowns, silver diamide fluoride (SDF), space maintainers, fissure sealant, reinforced splint and mineral trioxide aggregate.
Valuation and market data
| Last close | ₹202.84 |
|---|---|
| Market capitalisation | ₹848 crore |
| Enterprise value | ₹758 crore |
| P/E (TTM) | 0.00 |
| Price to book | 4.06 |
| Price to sales (TTM) | 2.86 |
| Book value per share | ₹49.91 |
| Dividend yield | 0.00% |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Listed since | Mon Jan 20 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹217 crore | ₹21 crore | ₹19 crore | 0.00 |
| Mar 2025 | ₹176 crore | ₹32 crore | ₹26 crore | 4.92 |
| Mar 2024 | ₹145 crore | ₹12 crore | ₹23 crore | 4.40 |
| Mar 2023 | ₹133 crore | ₹1 crore | ₹1 crore | 0.27 |
| Mar 2022 | ₹117 crore | ₹-2 crore | ₹-4 crore | -144.08 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 41.8% |
|---|---|
| Foreign institutions (FII) | 30.1% |
| Mutual funds | 10.1% |
| Other domestic institutions | 0.8% |
| Retail and others | 17.2% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.